Your NPR news source

The trials and triumphs of living with allergies

SHARE The trials and triumphs of living with allergies

Chicago’s mild winter has brought with it the early onset of springtime allergies. Blurred vision, sore throats and sneezes that could topple mountains are all making a forceful comeback, and it seems like everyone is affected.

Listen to this conversation on Eight Forty-Eight

That perception may be more accurate than you realize. Recent studies have shown that allergies are on the rise in most western countries, and it goes beyond the passing annoyance of noses rubbed raw. The CDC recently reported an 18% rise in severe food allergies between 1997-2007, and, following tragic, allergy-related deaths in Chicago and Virginia, families, businesses and schools are starting to take notice.

Throughout the country, public and private schools are instituting expansive policies concerning the treatment of students with allergies. Some are creating ‘peanut-free’ areas in classrooms and cafeterias, some are banning nut products all together. These new guidelines have struck some as overreactions, a violation of student rights by the school boards. To many, it’s simply another indication that food allergies are a serious problem, one that’s expanding at an alarming rate.

Tony will talk about both sides of the issue, as well as the science behind allergies, on Tuesday’s Eight Forty-Eight. He’ll be joined in-studio by Jenny Kales, an associate editor with Allergic Living magazine, who also runs the Nut-Free Mom blog; and local allergist Dr. Steve Handoyo. Call 312.923.9239 to join the conversation.

The Latest
Clinicians take walk-ins and appointments at some local libraries. The service is open to all Chicagoans, regardless of insurance or ability to pay. Host: Mary Dixon; Reporter: Shannon Heffernan
The investigation also reveals that many children are not being regularly tested for lead, although this is a city requirement.
CDC advisers are recommending the use of two separate COVID-19 vaccines for the youngest children made by Moderna and Pfizer-BioNTech, paving the way for vaccine rollout as early as next week.
The average out-of-stock rate for baby formula at retailers across the country was 43% during the first week of May, according to the firm Datasembly.